Bank Of New York Mellon Corp Ascendis Pharma A/S Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$104.9 - $126.78 $25.7 Million - $31.1 Million	245,419 New	245,419 $26.3 Billion
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $24.9 Million - $33.1 Million	250,650 New	250,650 $30.6 Million
Q3 2022 Nov 14, 2022	SELL	$84.03 - $110.23 $714,675 - $937,506	-8,505 Reduced 3.15%	261,441 $27 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $1.51 Million - $2.28 Million	-19,398 Reduced 6.7%	269,946 $25.1 Million
Q1 2022 May 11, 2022	BUY	$102.18 - $135.75 $5.04 Million - $6.69 Million	49,298 Added 20.54%	289,344 $34 Million
Q4 2021 Feb 11, 2022	SELL	$127.1 - $169.66 $265,257 - $354,080	-2,087 Reduced 0.86%	240,046 $32.3 Million
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $2.35 Million - $3.69 Million	-20,837 Reduced 7.92%	242,133 $38.6 Million
Q2 2021 Aug 11, 2021	BUY	$121.62 - $145.29 $18,972 - $22,665	156 Added 0.06%	262,970 $34.6 Million
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $12.6 Million - $17.5 Million	100,790 Added 62.21%	262,814 $33.9 Million
Q4 2020 Feb 09, 2021	BUY	$151.2 - $182.76 $1.49 Million - $1.8 Million	9,831 Added 6.46%	162,024 $27 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $2.04 Million - $2.34 Million	15,156 Added 11.06%	152,193 $23.5 Million
Q2 2020 Aug 12, 2020	BUY	$110.87 - $156.01 $1.09 Million - $1.53 Million	9,820 Added 7.72%	137,037 $20.3 Million
Q1 2020 May 06, 2020	SELL	$97.01 - $145.11 $669,369 - $1 Million	-6,900 Reduced 5.14%	127,217 $14.3 Million
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $12.3 Million - $18.7 Million	134,117 New	134,117 $18.7 Million
Q1 2019 May 14, 2019	SELL	$62.15 - $129.99 $7.67 Million - $16 Million	-123,415 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$55.16 - $69.67 $6.81 Million - $8.6 Million	123,415 New	123,415 $7.73 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account